Vertiseit - Efficiency program and exciting pipeline

Redeye retains its positive view of Vertiseit following the Q2 report. ARR growth remained solid, although a more cautious market impacted negatively. On the other hand, the pipeline is the “most exciting ever”, and efficiency measures support margin expansion in H2 and beyond.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/